The dome of the Capitol is reflected in a puddle in Washington February 17, 2012.REUTERS/Kevin Lamarque

Another debt ceiling debacle could sink the economy

Last year's Congressional debt standoff hurt consumer confidence more than the collapse of Lehman Brothers, Betsey Johnson and Justin Wolfers write. This time could be worse.  Read more at Counterparties  

U.S. approves two Novartis blood pressure pills

Related Topics

A general view shows the production plant of the pharmaceutical company Novartis in Schweizerhalle near Basel, Switzerland, July 21, 2008. REUTERS/Christian Hartmann

A general view shows the production plant of the pharmaceutical company Novartis in Schweizerhalle near Basel, Switzerland, July 21, 2008.

Credit: Reuters/Christian Hartmann

ZURICH | Mon Aug 4, 2008 7:50am EDT

ZURICH (Reuters) - U.S. regulators have approved two single-pill high blood pressure drugs, Diovan HCT and Exforge, from Switzerland's Novartis AG, the drugmaker said on Monday.

Both combination medicines were approved as initial therapies in patients likely to need multiple drugs to treat their high blood pressure, Novartis said in a statement.

(Reporting by Sam Cage)

Related Quotes and News

Company
Price
Related News
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.